Pfizer In Talks To Buy Drugmaker For $5 Billion: Report
Pfizer is one of the top makers of Covid-19 vaccines.(File) New York: American drugmaker Pfizer is close to a deal to purchase Global Blood Therapeutics, which manufactures a recently approved drug against sickle-cell anemia, for $5 billion, the Wall Street Journal has reported. Pfizer, one of the top makers of Covid-19 vaccines, hopes to conclude … Read more